A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.
McDonald AC, Vasey PA, Adams L, Walling J, Woodworth JR, Abrahams T, McCarthy S, Bailey NP, Siddiqui N, Lind MJ, Calvert AH, Twelves CJ, Cassidy J, Kaye SB.
McDonald AC, et al. Among authors: twelves cj.
Clin Cancer Res. 1998 Mar;4(3):605-10.
Clin Cancer Res. 1998.
PMID: 9533527
Clinical Trial.